KAYLA LEMON: Open Payments
NPI 1205310588 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$221 in 11 payments from 6 companies in 2025. Trend: 2023 $153 · 2024 $402 · 2025 $221
Food & beverage: $221
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $94 |
| Novartis Pharmaceuticals Corporation | 3 | $50 |
| AtriCure, Inc. | 1 | $23 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $21 |
| BridgeBio Pharma, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $14 |
Products named: Ozempic, LEQVIO, Wegovy, SYNERGY ABLATION SYSTEM, LifeVest, Attruby, REPATHA.
Industry payments across IN — which companies pay providers there.
